Antipsychotic Drugs Market Growth: Key Players and Market Strategies
Antipsychotic Drugs Market size was valued at USD 13.8 Billion in 2022 and is expected to reach USD 25.92 Billion By 2030 and grow at a CAGR of 8.2% over the forecast period of 2023-2030.
The Antipsychotic Drugs Market Report provides a
comprehensive analysis of the global antipsychotic drugs market, highlighting
key trends, growth drivers, challenges, and opportunities. The report aims to
assist industry stakeholders in making informed decisions and formulating
effective strategies.
The antipsychotic drugs market has witnessed significant
growth in recent years, driven by the rising prevalence of mental disorders
such as schizophrenia, bipolar disorder, and depression. These conditions
affect millions of people worldwide, leading to a growing demand for effective
treatment options.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2939
Antipsychotic drugs are primarily used to manage symptoms
associated with psychosis, including hallucinations, delusions, and
disorganized thinking. They work by targeting neurotransmitters in the brain to
restore chemical imbalances that contribute to these symptoms. The market
offers a wide range of antipsychotic medications, including both
first-generation (typical) and second-generation (atypical) drugs.
In recent years, there has been a shift towards atypical
antipsychotics due to their improved efficacy and reduced side effects compared
to typical antipsychotics. This trend is expected to continue driving market
growth as healthcare providers increasingly prescribe atypical medications as a
first-line treatment option.
KEY MARKET SEGMENTS
By Therapeutic Class
·
First-Generation
·
Second-Generation
By Application
·
Schizophrenia
·
Dementia
·
Bipolar Disorder
·
Depression
·
Others
By Distribution Channel
·
Hospital Pharmacies
·
Retail Pharmacies
·
Online Pharmacies
Major Players Listed in the Report are as Follows:
AstraZeneca Plc., Bristol-Myers Squibb, Pfizer Inc., Johnson
& Johnson (Janssen Pharmaceuticals), dr. Reddy Laboratories Limited, Eli
Lilly and Company, Teva Pharmaceutical Industries Ltd., Alkermes Plc., Otsuka
Holdings Co. Ltd., Abbvie lnc. and the final reports list additional
participants.
Other Report
Breast
Cancer Therapeutics Market Analysis
About US:
SNS Insider has been a leader in data and analytics globally
with its authentic consumer and market insights. The trust of our clients and
business partners has always been at the center of who we are as a company. We
are a business that leads the industry in innovation, and to support the
success of our clients, our highly skilled engineers, consultants, and data
scientists have consistently pushed the limits of the industry with innovative
methodology and measuring technologies.
We assist our clients to anticipate industrial, economic,
and consumer trends to drive disruptive change by fusing global experience with
local information from experts throughout the world. We bring context to
strategic and tactical data by bridging approaches based on data science and
field research, assisting you in addressing your most pressing problems and
spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Comments
Post a Comment